Author:
Hwee Jeremiah,Huynh Lynn,Du Shawn,Kwon Namhee,Jakes Rupert W.,Alfonso-Cristancho Rafael,Baylis Lee,Requena Gema,Khanal Anamika,Rothenberg Marc E.,Sheng Duh Mei
Subject
Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology
Reference34 articles.
1. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management;Shomali;Am J Hematol,2022
2. Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm;Leru;Clin Transl Allergy,2019
3. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management;Gotlib;Am J Hematol,2017
4. Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence;Crane;J Allergy Clin Immunol,2010
5. EMA. EU/3/04/213: Orphan Designation for the Treatment of Hypereosinophilic Syndrome. Available at: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu304213. Accessed May 14, 2022.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献